A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in mice.
The mosquito-borne Chikungunya virus (CHIKV) causes high fever and severe joint pain in humans. It is expected to spread in the future to Europe and has recently reached the USA due to globalization, climate change and vector switch. Despite this, little is known about the virus life cycle and, so f...
Saved in:
Main Authors: | Christopher Weber (Author), Sarah M Büchner (Author), Barbara S Schnierle (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2015-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates.
by: Karthik Mallilankaraman, et al.
Published: (2011) -
Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera.
by: Chong-Long Chua, et al.
Published: (2016) -
High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines.
by: In-Kyu Yoon, et al.
Published: (2015) -
Identification of Functional Determinants in the Chikungunya Virus E2 Protein.
by: Christopher Weber, et al.
Published: (2017) -
A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease.
by: Suganya Selvarajah, et al.
Published: (2013)